Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase 1 6Phase 1/2 5Phase 3 4Phase 4 2Phase NA 1Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 21Terminated 6Recruiting 6Withdrawn 4Active not recruiting 4Unknown 3Not yet recruiting 1

Sponsor Class

OTHER 4OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Other solid neoplasm 2Genitourinary 1Dermatologic 1

Conditions

Polycystic Ovary Syndrome 2Metabolic Diseases 2Infertility 2TP53 Y220C Mutation 1Melanoma 1Insulin Resistance 1Castration Sensitive Prostate Cancer 1Advanced Solid Tumor 1

Interventions

Cyclophosphamide 119Specimen Handling 104pembrolizumab 102Magnetic Resonance Spectroscopy 96fludarabine 92Biopsy 79Injections 53Nivolumab 41venetoclax 40Bevacizumab 40Fluorouracil 38Paclitaxel 37Cisplatin 36Cetuximab 35Carboplatin 35Gemcitabine 31fludarabine phosphate 30Radiotherapy 30Oxaliplatin 30Leucovorin 28Immunotherapy, Adoptive 25Drug Therapy 25Ipilimumab 24Azacitidine 23Irinotecan 21130-nm albumin-bound paclitaxel 21tislelizumab 20Temozolomide 20Radiation 20atezolizumab 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 1 × Recruiting × Metformin × Clear all
NCT07603505 2026-05-27

NAE-PCOS

Jinnah Sindh Medical University

Phase 1 Recruiting
116 enrolled

Infertility, Insulin Resistance, Metabolic Diseases, Polycystic Ovary Syndrome

NCT07372625 2026-03-12

A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.

PMV Pharmaceuticals, Inc

Phase 1 Recruiting
14 enrolled
Other solid neoplasm

TP53 Y220C Mutation

NCT07399535 2026-02-10

PCOS

Jinnah Postgraduate Medical Centre

Phase 1 Recruiting
116 enrolled

Infertility, Metabolic Diseases, Polycystic Ovary Syndrome

NCT06044025 2026-01-15

A Feasibility Study Evaluating a Role for Maintenance Therapy in Patients With Biochemically Progressive Castration Sensitive Prostate Cancer on Intermittent Androgen Deprivation Therapy

University of Arkansas

Phase 1 Recruiting
34 enrolled
Genitourinary

Castration Sensitive Prostate Cancer

NCT07098299 2025-11-06

Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies

Barbara Ann Karmanos Cancer Institute

Phase 1 Recruiting
60 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT03311308 2025-05-06

A Trial of Pembrolizumab and Metformin Versus Pembrolizumab Alone in Advanced Melanoma

University of Pittsburgh

Phase 1 Recruiting
30 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡